Variant report
Variant | esv3439024 |
---|---|
Chromosome Location | chr14:104715099-104720197 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000258748 | chromatin interactions |
ENSG00000228032 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs372562908 | chr14:104715105-104715106 | Weak transcription ZNF genes & repeats Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs3935837 | chr14:104715111-104715112 | Weak transcription ZNF genes & repeats Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs570992022 | chr14:104715112-104715113 | Weak transcription ZNF genes & repeats Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs539913264 | chr14:104715118-104715119 | Weak transcription ZNF genes & repeats Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs550004019 | chr14:104715138-104715139 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs139210088 | chr14:104715139-104715140 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs530209976 | chr14:104715144-104715145 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs149949064 | chr14:104715173-104715174 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187117978 | chr14:104715186-104715187 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs572223665 | chr14:104715300-104715301 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534645530 | chr14:104715305-104715306 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs546757655 | chr14:104715306-104715307 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs557293625 | chr14:104715311-104715312 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs577344387 | chr14:104715312-104715313 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs543070599 | chr14:104715324-104715325 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs191621951 | chr14:104715325-104715326 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs117687605 | chr14:104715330-104715331 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs371655957 | chr14:104715368-104715369 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532621752 | chr14:104715411-104715412 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs562434160 | chr14:104715414-104715415 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs79958001 | chr14:104715415-104715416 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs547828204 | chr14:104715418-104715419 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564425979 | chr14:104715461-104715462 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs142200723 | chr14:104715493-104715494 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs550338113 | chr14:104715494-104715495 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs115609845 | chr14:104715504-104715505 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs535666700 | chr14:104715511-104715512 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548887899 | chr14:104715527-104715528 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs565978349 | chr14:104715574-104715575 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs4614660 | chr14:104715591-104715592 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs57312174 | chr14:104715592-104715593 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs577179661 | chr14:104715651-104715652 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs150713350 | chr14:104715658-104715659 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs372735247 | chr14:104715659-104715660 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs568753355 | chr14:104715666-104715667 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs75113650 | chr14:104715720-104715721 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs76566829 | chr14:104715721-104715722 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs573634616 | chr14:104715722-104715723 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs542445136 | chr14:104715769-104715770 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs12432919 | chr14:104715772-104715773 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs547956750 | chr14:104715816-104715817 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs541704883 | chr14:104715841-104715842 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs117467353 | chr14:104715864-104715865 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533411340 | chr14:104715920-104715921 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs533991005 | chr14:104715982-104715983 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs28369657 | chr14:104715985-104715986 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs376950106 | chr14:104716008-104716009 | Weak transcription ZNF genes & repeats Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs543815345 | chr14:104716140-104716141 | Weak transcription ZNF genes & repeats Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs371626281 | chr14:104716146-104716147 | Weak transcription ZNF genes & repeats Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs563837369 | chr14:104716152-104716153 | Weak transcription ZNF genes & repeats Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
cataract | 16735990 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Developmental delay | 21147756 | CNVD |
Cancer | 20164920 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Biliary cancer | 19435499 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Acute lymphoblastic leukemia | 20139093 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Non-small cell lung cancer | 18320023 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Congenital heart defect | 22367666 | CNVD |
Developmental delay | 22367666 | CNVD |
Genitourinary abnormalities | 22367666 | CNVD |
Intellectual disability | 22367666 | CNVD |
Microcephaly | 22367666 | CNVD |
Muscularhypotonia | 22367666 | CNVD |
Ocular coloboma | 22367666 | CNVD |
Teratozoospermia | 22367666 | CNVD |
Cervical cancer | 21062161 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 21990379 | CNVD |
Breast cancer | 16417655 | CNVD |
22q11 deletion syndrome | 22511897 | CNVD |
Cancer | 21129771 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Schizophrenia | 21399695 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
14q deletion syndrome | 22511897 | CNVD |
Epilepsy | 22083797 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 17440070 | CNVD |
Neurocytoma | 17123091 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Acute lymphoblastic leukemia | 17315016 | CNVD |
Lung cancer | 17086460 | CNVD |
Mortal | 21835882 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Ependymoma | 20639864 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Breast cancer | 22522925 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:104710800-104716800 | ZNF genes & repeats | Foreskin Melanocyte Primary Cells skin01 | Skin |
2 | chr14:104713200-104719400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr14:104713800-104717400 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
4 | chr14:104714800-104715200 | Enhancers | Spleen | Spleen |
5 | chr14:104714800-104719000 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
6 | chr14:104715000-104718800 | Weak transcription | Fetal Muscle Leg | muscle |
7 | chr14:104715200-104715400 | Flanking Active TSS | Spleen | Spleen |
8 | chr14:104715400-104716000 | Enhancers | Spleen | Spleen |
9 | chr14:104716000-104716400 | Active TSS | Spleen | Spleen |
10 | chr14:104716800-104718400 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
11 | chr14:104718400-104719800 | ZNF genes & repeats | Foreskin Melanocyte Primary Cells skin01 | Skin |
12 | chr14:104718800-104719600 | Enhancers | Primary B cells from peripheral blood | blood |
13 | chr14:104718800-104721800 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
14 | chr14:104718800-104721800 | Enhancers | Fetal Muscle Leg | muscle |
15 | chr14:104719000-104719600 | Strong transcription | Fetal Adrenal Gland | Adrenal Gland |
16 | chr14:104719400-104720000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr14:104719600-104733800 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
18 | chr14:104719800-104720600 | Enhancers | Fetal Brain Male | brain |
19 | chr14:104720000-104720800 | Enhancers | Fetal Brain Female | brain |
20 | chr14:104720000-104728800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |